abstract |
The present invention provides a compound having a superior histone acetyltransferase inhibitory activity of EP300 and / or CREBBP, or a pharmacologically acceptable salt thereof. The compound represented by the formula (1) or a pharmacologically acceptable salt thereof is provided. Embedded image (Here, ring Q 1 , ring Q 2 , ring Q 3 , X, and L in the formula (1) have the same definitions as in the description.) [Selection diagram] None |